JUNS stock news · Jupiter Neurosciences
Get alerts for JUNS
Follow Jupiter Neurosciences (JUNS) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for JUNS12 health care companies are changing prices before the market opens on Wednesday.
NeutralJupiter Neurosciences' stock fell 8% to $2.62 per share. The article gives no business update explaining the move, so it does not change the company's outlook.
12 health care stocks changed a lot in prices after the market closed on Tuesday.
NeutralJupiter Neurosciences shares fell about 8% after hours, but the article gives no company news. The share-price move alone does not change the company's outlook.
On Thursday evening, 12 health care stocks changed a lot in price, with Prime Medicine jumping 13%.
NeutralJupiter Neurosciences shares rose 5.71% to $3.05 after-market; the article reports market moves only and does not change the company's outlook.
Jupiter Neurosciences, Inc. finalizes a significant definitive agreement (JUNS).
NeutralJupiter Neurosciences, Inc. has filed a Form 8-K detailing its entry into a material definitive agreement, which is a significant corporate event that could lead to new opportunities for the company. This development is likely to be viewed positively by investors as it may enhance the company's strategic position and financial outlook.
On Friday, Jupiter Neurosciences shares jumped nearly 69% due to a new patent secured by partner PharmAla Biotech.
NeutralJupiter Neurosciences' stock surged nearly 69% following the announcement of a new patent granted to its partner PharmAla Biotech, which enhances the intellectual property for their lead drug candidate. This development, along with a strategic shift in partnership, indicates strong potential for future growth and monetization of assets.
Jupiter Neurosciences, Inc. files Form 8-K outlining significant changes to security holder rights.
NeutralJupiter Neurosciences, Inc. has filed a Form 8-K detailing material modifications to the rights of security holders, which may lead to changes in governance and shareholder dynamics. This filing is crucial for investors to assess potential impacts on their holdings.